step 11 semaglutide Once-weekly 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial Weight regain and cardiometabolic effects – Switching between weight-loss medications -

Fresh, compounded medication paired with genetic insights ensures your dose is optimized for your biology, not just a standard retail protocol

Every time the door opens, the items on the door shelves are exposed to room temperature air directly

The interventions that genuinely help are the ones that address the underlying biology: protein, strength training, gut health, blood sugar balance, sleep, stress management, and where appropriate, targeted supplementation and HRT

Avoid rubbing the area, as this can lead to bruising

The medication is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2